QIAGEN Launches Bundibugyo Ebola Research Assays to Support Outbreak Surveillance
VENLO, Netherlands & GERMANTOWN, Md., May 28, 2026 QIAGEN announced the availability of two custom-designed research-use-only (RUO) QIAcuity digital...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
VENLO, Netherlands & GERMANTOWN, Md., May 28, 2026 QIAGEN announced the availability of two custom-designed research-use-only (RUO) QIAcuity digital...
HYDERABAD, India, Dec. 17, 2025 — Havih Envirosciences, a subsidiary of Maxwell Biosciences, announced a strategic partnership with the...
